Want to see SCND full AI Analyst Report?
Scientific Industries (SCND) AI Stock Analysis
Scientific Industries
(Other OTC:SCND)
The score is held down primarily by weak financial performance (continued losses, steep revenue decline, margin compression, and sustained cash burn). Technicals are neutral-to-slightly constructive and corporate events are modestly positive due to leadership continuity, but valuation lacks support given negative earnings and no dividend yield data.
Scientific Industries (SCND) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $7.75M
- Dividend Yield
- ―
- Average Volume (3M)
- 6,264
- Price to Earnings (P/E)
- -13.0
- Beta (1Y)
- 0.31
- Revenue Growth
- -44.48%
- EPS Growth
- 90.56%
- Country
- US
- Employees
- 55
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Hardware, Equipment & Parts
Scientific Industries Business Overview & Revenue Model
Company Description
Scientific Industries, Inc. operates as a global enterprise specializing in the development, production, and distribution of a comprehensive range of benchtop laboratory instrumentation and advanced bioprocessing systems. Their product line features...
Scientific Industries Earnings Call Summary
The earnings call highlighted significant growth in the VIVID pill counter business and successful cost-cutting initiatives, alongside promising developments and strategic partnerships in the bioprocessing segment. However, challenges in the European market remain a concern.
Q3-2024 Updates
Positive Updates
Negative Updates
Company Guidance
During the third quarter of 2024, Scientific Industries demonstrated significant progress in its strategic transformation into a life sciences tool business with notable growth in sales, margins, and recurring revenue. The legacy Genie business experienced a recovery, generating positive cash flow that supports investments in the VIVID pill counter business, which saw a 50% increase in sales compared to the previous quarter and 12% year-over-year growth. The company is excited about the upcoming launch of the VIVID workstation, a new all-in-one pill counter and pharmacy management system. In the bioprocessing segment, sales increased by 12% compared to the previous year, with a remarkable 61% year-over-year growth in the U.S. market. Efforts to improve cost efficiency resulted in a reduction of operating expenses by over $1 million, or 22%, compared to the previous year. The company also reported a positive EBITDA margin of 14% for its U.S. entity in September, marking a significant milestone. Scientific Industries continues to invest in R&D and commercial activities, with a growing commercial pipeline and the successful launch of the DOTS platform, reflecting its potential to deliver long-term shareholder value.
Scientific Industries Financial Statement Overview
Summary
Overall fundamentals are weak: income statement and cash flow show continued losses, a sharp revenue decline (~44% in 2025), material gross margin compression (~26% in 2025), and ongoing negative operating/free cash flow. The main offset is a relatively strong balance sheet with low leverage and a meaningful equity base, which provides some near-term resilience but does not resolve the underlying profitability and cash-burn risk.
Income Statement
18Very NegativeBalance Sheet
62PositiveCash Flow
15Very Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Jun 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.73M | 5.05M | 10.71M | 11.11M | 10.48M | 9.78M |
| Gross Profit | 1.67M | 1.30M | 4.73M | 5.10M | 4.64M | 4.98M |
| EBITDA | -6.79M | -7.89M | -5.89M | -8.51M | -7.41M | -4.46M |
| Net Income | -742.30K | -1.22M | -6.45M | -9.09M | -8.15M | -3.11M |
Balance Sheet | ||||||
| Total Assets | 10.11M | 12.61M | 11.56M | 16.73M | 18.07M | 29.01M |
| Cash, Cash Equivalents and Short-Term Investments | 4.55M | 6.66M | 2.57M | 5.72M | 6.20M | 13.42M |
| Total Debt | 790.70K | 966.70K | 1.00M | 1.33M | 1.43M | 1.49M |
| Total Liabilities | 2.03M | 1.94M | 2.44M | 2.85M | 3.28M | 2.78M |
| Stockholders Equity | 8.07M | 10.66M | 9.12M | 13.89M | 14.79M | 26.22M |
Cash Flow | ||||||
| Free Cash Flow | -6.60M | -8.21M | -3.78M | -6.29M | -6.20M | -3.56M |
| Operating Cash Flow | -6.95M | -8.15M | -3.68M | -6.16M | -5.70M | -3.30M |
| Investing Cash Flow | 3.99M | 3.83M | 2.87M | -735.10K | 3.61M | -10.88M |
| Financing Cash Flow | 500.00K | 1.95M | 645.70K | 5.75M | 2.31M | 16.31M |
Scientific Industries Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SCND, the sentiment is Negative. The current price of 0.60 is below the 20-day moving average (MA) of 0.67, below the 50-day MA of 0.75, and below the 200-day MA of 0.69, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 17.18 is Positive, neither overbought nor oversold. The STOCH value of 9.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SCND.
Scientific Industries Risk Analysis
Scientific Industries disclosed 12 risk factors in its most recent earnings report. Scientific Industries reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksScientific Industries Peers Comparison
Overall Rating
- SCND46Neutral
ELTK46Neutral
SOBR39Underperform
SVRE39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| SCND | 46Neutral | $7.75M | -13.00 | -7.37% | ― | -44.48% | 90.56% |
| ELTK | 46Neutral | $42.41M | -6.70 | -13.57% | ― | -2.20% | -297.64% |
| SOBR | 39Underperform | $355.56K | -0.04 | -310.87% | ― | 17.67% | 92.17% |
| SVRE | 39Underperform | $343.88M | -0.03 | -329.57% | ― | -68.00% | 97.75% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SCND | Scientific Industries | 0.60 | -0.04 | -5.47% | |
| ELTK | Eltek | 6.10 | -5.20 | -46.02% | |
| IMTE | Integrated Media Technology | 0.42 | -0.39 | -48.14% | |
| SOBR | Sobr Safe, Inc. | 0.04 | -3.05 | -98.58% | |
| OST | Ostin Technology Group Co., Ltd. | 1.70 | 0.00 | 0.00% | |
| SVRE | SaverOne 2014 Ltd. ADR | 0.62 | -14.18 | -95.83% |
Scientific Industries Corporate Events
Scientific Industries Strengthens Executive Leadership Through New Agreements
PositiveOn October 1, 2026, Scientific Industries entered into a new employment agreement with Chief Financial Officer Zachary Rovinsky, securing his role through September 30, 2028 with an annual salary of $210,000, a bonus opportunity up to 10%, and schedu...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 02, 2026